About NeuroNexus
NeuroNexus is a Healthcare company based in Ann Arbor (United States) founded in 2004, and was acquired by NEL in December 2018. Micro-electrode arrays are developed for neural electrophysiology applications. NeuroNexus offers products and services including Electrodes, Instrumentation, and Software. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is NEURONEXUS TECHNOLOGIES INC. Its competitors include Blackrock Neurotech, Precision Neuroscience and Endonovo Therapeutics; 2 of its 3 listed competitors have raised funding.
Company details
NeuroNexus is a neurotechnology company which develops neural interface technology, components, and systems for neuroscience and clinical applications. The companys microelectronic, fluidic, and optical technologies are used to map brain function, detect neural activity, and stimulate or modulate neural circuits when brain function is impaired. The company offers neural probes, SmartBox (data acquisition system designed to interface with both micro and macro electrodes), cardiac and autonomic nervous system, dDrive (disposable head-mounted drive), accessories, and other services.
- Headquarters Ann Arbor, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website neuronexus.com
- Social LinkedIn X YouTube
- Acquired by NEL (Dec 2018)
- Legal Name Neuronexus Technologies Inc
Products & Services of NeuroNexus
NeuroNexus offers a comprehensive portfolio of products and services, including Electrodes, Instrumentation, and Software.
Advanced multi-channel electrodes for neuroscience research targets.
Hardware for electrophysiology data collection and analysis.
Tools for neural data visualization and research applications.
Apps and channels of NeuroNexus
its YouTube channel NeuroNexus Technologies has 543 subscribers and 30 videos.
Videos from NeuroNexus
The most watched videos on NeuroNexus's YouTube channel, NeuroNexus Technologies (543 subscribers). Click a video to play it here.
More on NeuroNexus Technologies.
Funding Insights of NeuroNexus
- Total Rounds 10
- Last Round Grant — $242,354
- First Round $799,674
(Mar 2006)
- Investors Count 1
All 10 funding rounds of NeuroNexus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $242,354 | Grant | – | – | |
| Jun 2011 | $2.98M | Grant | – | – | |
| Mar 2011 | $175,576 | Grant | – | – | |
| Mar 2011 | $175,576 | Grant | – | – | |
| Feb 2010 | $221,890 | Grant | – | – | |
| Jan 2010 | $221,890 | Grant | – | – | |
| Feb 2008 | $799,674 | Grant | – | – | |
| Aug 2007 | $799,674 | Grant | – | – | |
| Aug 2007 | $2.98M | Grant | – | – | |
| Mar 2006 | $799,674 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in NeuroNexus
NeuroNexus has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and NEL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| nel.ca |
Investor details for NeuroNexus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NeuroNexus
8 people are tracked at NeuroNexus (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Linda Thompson | Finance Director | Leadership |
Jamille Hetke | VP Engineering | Leadership |
Rio Vetter | Chief Operating Officer & Chief Technology Officer | Leadership |
Daryl Kipke | CEO and Managing Director | Leadership |
Priyanka Sehgal | Director Of Operations | Leadership |
Bill Willis | Purchasing Buyer / Shipping & Receiving Coordinator | Team |
Andrea Walkuski | Senior Accountant | Team |
Allen Angle | Process Engineer | Team |
Complete people profiles for NeuroNexus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NeuroNexus
4 dated milestones of NeuroNexus across 16 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroNexus is founded.
- Funding First funding round of $800K.
- Exit Acquired by NEL.
- Funding Latest funding round, Grant, of $242K.
Competitors of NeuroNexus
NeuroNexus has 3 listed competitors in our database, 2 of them funded. They include Blackrock Neurotech, Precision Neuroscience and Endonovo Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| precisionneuro.io | 2021 | New York, United States | $182.65M | 22 | Brain-computer interfaces developed for medical treatment and drug development. | |
| endonovo.com | 2011 | Los Angeles, United States | Bioelectronic devices are developed for regenerative medicine therapies. |
Detailed competitors of NeuroNexus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NeuroNexus
The website of NeuroNexus (neuronexus.com) receives about 7.8K visits a month.
- Monthly visits7.8K
▲ 25.7% vs previous month
Websites whose visitors overlap most with NeuroNexus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
neurotechx.com | neurotechx.com | 100% | #1,842,250 | – | |
| blackrockneurotech.com | 89% | 35K | #1,022,772 | View details | |
| unemed.com | 88% | 5.4K | #3,495,300 | View details | |
brainmind.org | brainmind.org | 66% | #3,020,265 | – | |
| micromachines.com | 49% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for NeuroNexus
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as NeuroNexus (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuronexus
Complete news archive for NeuroNexus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroNexus
NeuroNexus was founded in 2004 and raised its 1st funding round 2 years after it was founded.
NeuroNexus is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
NeuroNexus is a neurotechnology company which develops neural interface technology, components, and systems for neuroscience and clinical applications. The companys microelectronic, fluidic, and optical technologies are used to map brain function, detect neural activity, and stimulate or modulate neural circuits when brain function is impaired. The company offers neural probes, SmartBox (data acquisition system designed to interface with both micro and macro electrodes), cardiac and autonomic nervous system, dDrive (disposable head-mounted drive), accessories, and other services.
NeuroNexus's top competitors include Blackrock Neurotech, Precision Neuroscience and Endonovo Therapeutics.
NeuroNexus offers Electrodes, Instrumentation, and Software.
NeuroNexus has 2 investors. Key investors include HHS, and NEL.
NeuroNexus operates through Neuronexus Technologies Inc.
Yes. NeuroNexus was acquired by NEL in December 2018.